168 related articles for article (PubMed ID: 6096607)
21. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
22. [Effects of angiotensin converting enzyme inhibitor captopril on blood pressure in "juvenile" essential hypertension].
Ando K; Fujita T; Sato Y; Yanashita K; Noda H
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):399-404. PubMed ID: 6750184
[No Abstract] [Full Text] [Related]
23. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
[TBL] [Abstract][Full Text] [Related]
24. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
25. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
26. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K
Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
[No Abstract] [Full Text] [Related]
27. [Acute effect of MK-421 (enalapril) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system in hypertensive patients].
Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
Kokyu To Junkan; 1985 Jun; 33(6):811-5. PubMed ID: 2994193
[No Abstract] [Full Text] [Related]
28. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
29. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
Nishimura K; Miyazaki M; Okunishi H; Toda N
Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
[TBL] [Abstract][Full Text] [Related]
30. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
Saruta T; Suzuki H; Okuno T; Kondo K
Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110
[TBL] [Abstract][Full Text] [Related]
33. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
34. Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
Jover B; Mimran A
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):209S-214S. PubMed ID: 6099736
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Sweet CS
Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
[TBL] [Abstract][Full Text] [Related]
36. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
Lindsjö M; Danielson BG; Weiss L; Wikström B
Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
[TBL] [Abstract][Full Text] [Related]
38. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
Burnier M; Biollaz J; Brunner HR; Turini GA; Gavras H
Am J Cardiol; 1982 Apr; 49(6):1550-1. PubMed ID: 6280484
[No Abstract] [Full Text] [Related]
39. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
[No Abstract] [Full Text] [Related]
40. [Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension].
Miyazaki N; Shionoiri H; Uneda S; Yasuda G; Gotoh E; Fujishima S; Kaneko Y; Kawahara Y; Yamazaki Y
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):421-8. PubMed ID: 6750186
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
